ALIGNMENT HEALTHCARE INC (ALHC)

US01625V1044 - Common Stock

10.86  +0.14 (+1.31%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALHC. ALHC was compared to 108 industry peers in the Health Care Providers & Services industry. ALHC has a bad profitability rating. Also its financial health evaluation is rather negative. ALHC is valued quite expensive, but it does show an excellent growth.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALHC had negative earnings in the past year.
In the past year ALHC has reported a negative cash flow from operations.
ALHC had negative earnings in each of the past 5 years.
In multiple years ALHC reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -20.82%, ALHC is doing worse than 80.37% of the companies in the same industry.
The Return On Equity of ALHC (-125.84%) is worse than 79.44% of its industry peers.
Industry RankSector Rank
ROA -20.82%
ROE -125.84%
ROIC N/A
ROA(3y)-26.52%
ROA(5y)-21.89%
ROE(3y)-73.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 10.45%, ALHC is doing worse than 76.64% of the companies in the same industry.
ALHC's Gross Margin has declined in the last couple of years.
ALHC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.99%
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

ALHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALHC has more shares outstanding
ALHC has a worse debt/assets ratio than last year.

2.2 Solvency

ALHC has an Altman-Z score of 3.52. This indicates that ALHC is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.52, ALHC is in the better half of the industry, outperforming 74.77% of the companies in the same industry.
ALHC has a Debt/Equity ratio of 1.84. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.84, ALHC is doing worse than 75.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF N/A
Altman-Z 3.52
ROIC/WACCN/A
WACC9.24%

2.3 Liquidity

ALHC has a Current Ratio of 1.60. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.60, ALHC is doing good in the industry, outperforming 60.75% of the companies in the same industry.
A Quick Ratio of 1.60 indicates that ALHC should not have too much problems paying its short term obligations.
The Quick ratio of ALHC (1.60) is better than 62.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6

More info and screens

7

3. Growth

3.1 Past

ALHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.33%, which is quite good.
Looking at the last year, ALHC shows a very strong growth in Revenue. The Revenue has grown by 43.46%.
ALHC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.88% yearly.
EPS 1Y (TTM)8.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)43.46%
Revenue growth 3Y23.88%
Revenue growth 5YN/A
Sales Q2Q%51.61%

3.2 Future

ALHC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.71% yearly.
Based on estimates for the next years, ALHC will show a very strong growth in Revenue. The Revenue will grow by 28.19% on average per year.
EPS Next Y10.55%
EPS Next 2Y15.91%
EPS Next 3Y14.01%
EPS Next 5Y20.71%
Revenue Next Year48.23%
Revenue Next 2Y38.41%
Revenue Next 3Y32.88%
Revenue Next 5Y28.19%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALHC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ALHC's earnings are expected to grow with 14.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.91%
EPS Next 3Y14.01%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALHC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALIGNMENT HEALTHCARE INC

NASDAQ:ALHC (12/26/2024, 12:40:47 PM)

10.86

+0.14 (+1.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)N/A N/A
Inst Owners46.93%
Inst Owner Change-1.24%
Ins Owners4.34%
Ins Owner Change-4.94%
Market Cap2.08B
Analysts81.05
Price Target13.17 (21.27%)
Short Float %10.21%
Short Ratio6.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.42%
Min EPS beat(2)3.21%
Max EPS beat(2)11.63%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-10.3%
Max EPS beat(4)11.63%
EPS beat(8)5
Avg EPS beat(8)6.39%
EPS beat(12)9
Avg EPS beat(12)13.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)2.53%
Max Revenue beat(2)4.75%
Revenue beat(4)4
Avg Revenue beat(4)3.36%
Min Revenue beat(4)2.53%
Max Revenue beat(4)4.75%
Revenue beat(8)7
Avg Revenue beat(8)2.66%
Revenue beat(12)11
Avg Revenue beat(12)3.66%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)24.73%
PT rev (3m)29.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.89%
EPS NY rev (1m)0.06%
EPS NY rev (3m)-233.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.05%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)29.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.84
P/FCF N/A
P/OCF N/A
P/B 18.17
P/tB 27.69
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.75
OCFYN/A
SpS12.87
BVpS0.6
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.82%
ROE -125.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.45%
FCFM N/A
ROA(3y)-26.52%
ROA(5y)-21.89%
ROE(3y)-73.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.99%
GM growth 5YN/A
F-Score2
Asset Turnover3.56
Health
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 163.57%
Cap/Sales 1.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 3.52
F-Score2
WACC9.24%
ROIC/WACCN/A
Cap/Depr(3y)141.79%
Cap/Depr(5y)117.76%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y10.55%
EPS Next 2Y15.91%
EPS Next 3Y14.01%
EPS Next 5Y20.71%
Revenue 1Y (TTM)43.46%
Revenue growth 3Y23.88%
Revenue growth 5YN/A
Sales Q2Q%51.61%
Revenue Next Year48.23%
Revenue Next 2Y38.41%
Revenue Next 3Y32.88%
Revenue Next 5Y28.19%
EBIT growth 1Y12.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year97.03%
EBIT Next 3Y40.03%
EBIT Next 5Y33.32%
FCF growth 1Y-450.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-295.66%
OCF growth 3YN/A
OCF growth 5YN/A